摘要
目的探讨缩宫素在足月妊娠引产中的临床效果。方法将2007年3月—2011年1月收治的90例初产妇应用缩宫素进行晚期妊娠引产,观察其临床疗效。结果本研究结果显示宫颈评分的高低与引产成功率成正比,用药12h后宫颈成熟度为(8.72±2.31)分,其中有效77例(85.6%),用药至临床时间为10.6h,发生新生儿窒息4例(4.44%),表明缩宫素静脉滴注引产并不增加新生儿窒息的发生。结论缩宫素是一种安全有效、方便的促宫颈成熟和计划引产药物,且对新生儿无明显不良反应。
Objective To investigate the clinical effect of oxytocin induction of labor in term pregnancy.Methods The hospital from March 2007 to January 2011 totally 90 patients were treated by early application of oxytocin to maternal late pregnancy labor induction,observe the clinical efficacy.Results The results showed that the level of cervical score is proportional with the success rate of labor induction,cervical ripening 12 hours after administration degree（8.72 ± 2.31） points,effective 77 cases（85.6%） ,medication to 10.6 hours of clinical time,4 cases of neonatal asphyxia（4.44%） ,indicating that the intravenous oxytocin induction of labor does not increase the incidence of neonatal asphyxia.Conclusions Oxytocin is a safe,effective and convenient program for cervical ripening and labor induction drugs and no significant adverse effects on the newborn.
出处
《医药论坛杂志》
2011年第10期91-92,95,共3页
Journal of Medical Forum
关键词
足月妊娠
引产
缩宫素
Full-term pregnancy
Induced labor
Oxytocin
